Glen Eagle Advisors’s Regenxbio RGNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.23K	Hold	150	–	–	﹤0.01%	904
2025 Q1	$1.07K	Hold	150	–	–	﹤0.01%	922
2024 Q4	$1.16K	Hold	150	–	–	﹤0.01%	947
2024 Q3	$1.57K	Hold	150	–	–	﹤0.01%	940
2024 Q2	$1.76K	Hold	150	–	–	﹤0.01%	919
2024 Q1	$3.16K	Hold	150	–	–	﹤0.01%	850
2023 Q4	$2.69K	Hold	150	–	–	﹤0.01%	830
2023 Q3	$2.47K	Hold	150	–	–	﹤0.01%	831
2023 Q2	$3K	Hold	150	–	–	﹤0.01%	813
2023 Q1	$2.84K	Hold	150	–	–	﹤0.01%	804
2022 Q4	$3.4K	Hold	150	–	–	﹤0.01%	778
2022 Q3	$3.97K	Hold	150	–	–	﹤0.01%	745
2022 Q2	$3.71K	Hold	150	–	–	﹤0.01%	750
2022 Q1	$4.98K	Hold	150	–	–	﹤0.01%	714
2021 Q4	$4.91K	Hold	150	–	–	﹤0.01%	714
2021 Q3	$6.29K	Hold	150	–	–	﹤0.01%	784
2021 Q2	$5.83K	Hold	150	–	–	﹤0.01%	792
2021 Q1	$5.12K	Hold	150	–	–	﹤0.01%	765
2020 Q4	$6.8K	Hold	150	–	–	﹤0.01%	690
2020 Q3	$4.13K	Hold	150	–	–	﹤0.01%	718
2020 Q2	$5.53K	Sell	150 -100	-40%	-$3.68K	﹤0.01%	652
2020 Q1	$8.1K	Sell	250 -200	-44%	-$6.48K	0.01%	547
2019 Q4	$18.4K	Hold	450	–	–	0.01%	476
2019 Q3	$16K	Hold	450	–	–	0.01%	437
2019 Q2	$23.1K	Buy	450 +107	+31%	+$5.5K	0.02%	386
2019 Q1	$19.7K	Hold	343	–	–	0.01%	387
2018 Q4	$14.4K	Hold	343	–	–	0.01%	409
2018 Q3	$25.9K	Buy	343 +93	+37%	+$7.02K	0.02%	337
2018 Q2	$17.9K	Hold	250	–	–	0.01%	375
2018 Q1	$7.46K	Buy	+250	New	+$7.46K	0.01%	474